"4 years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who received a spacer],” says Michael R. Folkert, MD, PhD.
Michael R. Folkert, MD, PhD
Advertisement
Articles by Michael R. Folkert, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Lymph Node Dissection Following Systemic Therapy in MIBC
2
European Commission approves perioperative EV/pembrolizumab for cisplatin-ineligible MIBC
3
NCCN recommends ctDNA-MRD testing to guide adjuvant treatment post-cystectomy
4
Fred Saad, MD, highlights PSA end points from the phase 3 PSMAddition trial
5